N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142964 |
| CAS No | NA |
| Mol.F. | C13H10FN3O2 |
| Mol.Wt. | 259.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142965 |
| CAS No | NA |
| Mol.F. | C22H18N8O2 |
| Mol.Wt. | 426.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142966 |
| CAS No | NA |
| Mol.F. | C21H15FN8O2 |
| Mol.Wt. | 430.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142967 |
| CAS No | NA |
| Mol.F. | C22H17FN8O2 |
| Mol.Wt. | 444.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142968 |
| CAS No | NA |
| Mol.F. | C39H32FN11O3 |
| Mol.Wt. | 721.76 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142969 |
| CAS No | NA |
| Mol.F. | C22H19FN8O3 |
| Mol.Wt. | 462.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142970 |
| CAS No | NA |
| Mol.F. | C20H25N3O5 |
| Mol.Wt. | 387.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142971 |
| CAS No | NA |
| Mol.F. | C16H16N2O5 |
| Mol.Wt. | 316.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142972 |
| CAS No | NA |
| Mol.F. | C17H18N2O5 |
| Mol.Wt. | 330.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142973 |
| CAS No | NA |
| Mol.F. | C20H25N3O6 |
| Mol.Wt. | 419.48 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142974 |
| CAS No | NA |
| Mol.F. | C11H13N3O2 |
| Mol.Wt. | 219.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142975 |
| CAS No | NA |
| Mol.F. | C19H23N3O4 |
| Mol.Wt. | 357.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142976 |
| CAS No | NA |
| Mol.F. | C25H24N2O8 |
| Mol.Wt. | 480.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142977 |
| CAS No | 2512237-43-1 |
| Mol.F. | C6H6N2O2 |
| Mol.Wt. | 138.1g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142978 |
| CAS No | NA |
| Mol.F. | C16H16ClN3O4S |
| Mol.Wt. | 393.84 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142979 |
| CAS No | NA |
| Mol.F. | C24H27N3O5 |
| Mol.Wt. | 437.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |